Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Neumora Therapeutics Inc.’s stock clocked out at $12.92, down -1.22% from its previous closing price of $13.08. In other words, the price has decreased by -$1.22 from its previous closing price. On the day, 0.8 million shares were traded. NMRA stock price reached its highest trading level at $13.44 during the session, while it also had its lowest trading level at $12.77.
Ratios:
To gain a deeper understanding of NMRA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.22 and its Current Ratio is at 17.22. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on July 22, 2024, initiated with a Buy rating and assigned the stock a target price of $23.
On July 08, 2024, Mizuho started tracking the stock assigning a Outperform rating and target price of $20.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $13.Deutsche Bank initiated its Hold rating on December 12, 2023, with a $13 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 17 ’24 when Lenz Robert A. sold 30,788 shares for $11.81 per share. The transaction valued at 363,736 led to the insider holds 339,205 shares of the business.
Lenz Robert A. sold 10,676 shares of NMRA for $129,091 on Sep 18 ’24. The Head of R&D now owns 328,529 shares after completing the transaction at $12.09 per share. On Sep 18 ’24, another insider, Lenz Robert A., who serves as the Officer of the company, bought 10,676 shares for $12.09 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMRA now has a Market Capitalization of 2067561728 and an Enterprise Value of 1699526528.
Stock Price History:
Over the past 52 weeks, NMRA has reached a high of $21.00, while it has fallen to a 52-week low of $8.33. The 50-Day Moving Average of the stock is 9.26%, while the 200-Day Moving Average is calculated to be 0.44%.
Shares Statistics:
It appears that NMRA traded 872.32K shares on average per day over the past three months and 1281660 shares per day over the past ten days. A total of 158.83M shares are outstanding, with a floating share count of 54.90M. Insiders hold about 65.69% of the company’s shares, while institutions hold 27.63% stake in the company. Shares short for NMRA as of 1726185600 were 9523723 with a Short Ratio of 10.92, compared to 1723680000 on 9601726. Therefore, it implies a Short% of Shares Outstanding of 9523723 and a Short% of Float of 11.350001.
